|
|||||
|
|
Research and development of Chinese anti-COVID-19 drugs |
|
| Institution: | 1. Institute of Clinical Pharmacology, Peking University First Hospital, Beijing 100034, China;2. Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China;3. Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, Shanghai 201203, China |
| Abstract: | |
| Keywords: | Chinese anti-COVID-19 drug Small-molecule drug Neutralizing antibody Protein drug Traditional Chinese medicine Natural product Drug candidate Development prospect |
| 本文献已被 ScienceDirect 等数据库收录！ | |